Latest Breaking News On - Ghadeerk dawwas - Page 1 : comparemela.com

Apixaban Compared to Rivaroxaban for A-Fib and Valvular Heart Disease

Apixaban Compared to Rivaroxaban for A-Fib and Valvular Heart Disease
renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.

University of pennsylvaniaUnited statesGhadeerk dawwasHealthday news

Apixaban Compared to Rivaroxaban for A-Fib and Valvular Heart Disease

Apixaban Compared to Rivaroxaban for A-Fib and Valvular Heart Disease
koamnewsnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koamnewsnow.com Daily Mail and Mail on Sunday newspapers.

University of pennsylvaniaUnited statesGhadeerk dawwasApixaban comparedValvular heartCompared to rivaroxaban forFib and valvular heartHealthday news

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

The study is the latest showing apixaban may be the safest of the DOACs when it comes to bleeding, say experts.

United statesGhadeerk dawwasNeena abrahamDaiichi sankyoBayer janssenBristol myers squibbAmerican heart associationHeart rhythm societyUniversity of pennsylvania perelman school medicineAmerican college of cardiologyBoehringer ingelheimInternal medicinePennsylvania perelman schoolMayo clinicAmerican collegeNot ready

Stroke, systemic embolism risk halved in AF patients with VHD who took apixaban versus Rivaroxaban

According to researchers at the Perelman School of Medicine at the University of Pennsylvania patients of Atrial fibrillation with VHD receiving apixaban had a lower risk for ischemic stroke or.

United statesSean hennessyGhadeerk dawwasGhadeer dawwasGeoffreyd barnesJamesd lewisAdam cukerPenn centerUniversity of pennsylvaniaPerelman school of medicinePerelman schoolReal world effectivenessAnnals of internal medicineHeart diseaseApixaban versusAtrial fibrillation

Apixaban Outmatches Rivaroxaban for VTE in Study

These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the study.

New yorkUnited statesUniversity of pennsylvaniaGhadeerk dawwasColleen edwardsThomas wakefieldDamone houghtonIcahn school of medicine at mount sinaiUniversity of michigan health frankel cardiovascular centerClinformatics data martMay have missed some nuancePossible outcomesMichigan health frankel cardiovascular centerAnn arborMayo clinicTrial needed